Kim D. Blickenstaff - Aug 6, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ David B. Berger, Attorney-in-Fact for Kim D. Blickenstaff
Stock symbol
TNDM
Transactions as of
Aug 6, 2021
Transactions value $
-$8,917,607
Form type
4
Date filed
8/10/2021, 04:27 PM
Previous filing
Jun 15, 2021
Next filing
Aug 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Sale -$306K -2.8K -0.7% $109.39 400K Aug 6, 2021 See Footnote F1, F2, F3
transaction TNDM Common Stock Sale -$6.54M -60.8K -15.21% $107.64 339K Aug 9, 2021 See Footnote F1, F3, F4
transaction TNDM Common Stock Sale -$2.07M -19.2K -5.68% $107.64 320K Aug 9, 2021 See Footnote F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.
F2 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.01 to $109.71. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F3 The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
F4 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $107.00 to $107.98. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F5 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $108.00 to $108.63. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.